Ardelyx Receives Complete Response Letter from U.S. FDA for New Drug Application for Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis
Stock Information for Ardelyx Inc.
Loading
Please wait while we load your information from QuoteMedia.